ClinicalTrials.gg
RecruitingNCT06986421P-TECH-AVCUpdated Jul 16, 2025

Perception of Advanced Rehabilitation Technologies Among Post-Stroke Patients and Rehabilitation Staff

An observational study in Post Stroke, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-16.

Sponsored by Hospices Civils de Lyon · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Stroke by Hospices Civils de Lyon — 13 open to participants now, 14 under way, none of them phase 3. Stroke · Hospices Civils de Lyon.

Planned enrollment
12th of 14
80 · median 348
Started
2025
with 3 others
Observational
14 of 40
5 open now
Primary completion
2026-07
later than 5 of 13 live
Registered
37th of 40
by date

Among the 40 studies in Stroke by Hospices Civils de Lyon, this one is the 12th largest by planned enrollment of the 14 observational ones that give a count, is one of 4 that started in 2025, is one of 14 observational ones, reaches primary completion later than 5 of the 13 other live ones, and was the 37th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

13 of the 40 studies in Stroke by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 13 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Stroke by Hospices Civils de Lyon, or all of them as a file.
02

Study summary

This observational study aims to assess the perception of advanced rehabilitation technologies among three key groups involved in stroke recovery: post-stroke patients, physicians specialized in Physical and Rehabilitation Medicine, and allied health professionals. The study is conducted at HCL - Renée Sabran Hospital , specifically within the Kermes 2 department. Participants are selected using a non-probability sampling method, based on predefined inclusion and exclusion criteria. Data will be collected using a structured, author-developed questionnaire designed to evaluate attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The questionnaire is applied at a single time point after obtaining informed consent. This research responds to the growing integration of technology in neurorehabilitation and seeks to identify potential barriers or facilitators to its adoption in clinical practice.

The hypothesis is that there is a significant difference in perception and acceptance of advanced rehabilitation technologies between the three groups, influenced by their respective roles, experience, and level of exposure to such technologies.

03

Conditions studied

  • Post Stroke

Browse trials for

Keywords

  • Rehabilitation
  • Stroke
  • Advanced Technology
  • Perception
  • Questionnaire
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Participants will be recruited from HCL - Renée Sabran Hospital, located in the PACA region (Provence-Alpes-Côte d'Azur), specifically from the Kermes 2 department, as well as through professional medical networks. The study population includes three main groups: (1) patients with a confirmed diagnosis of stroke, whether or not they have been exposed to advanced rehabilitation technologies; (2) physicians specialized in Physical and Rehabilitation Medicine involved in stroke management; and (3) allied health professionals (e.g., physiotherapists, psychologists, occupational therapists, speech therapists, neuropsychologists, psychomotor therapists) actively working in post-stroke rehabilitation settings. Recruitment will focus on individuals affiliated with institutions offering neurological rehabilitation services.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients: Patients diagnosed with stroke, whether or not they have benefited from advanced rehabilitation technologies.
  • Physicians: Physicians specialized in Physical and Rehabilitation Medicine who manage patients with stroke.
  • Allied health professionals: Physiotherapists, psychologists, occupational therapists, speech therapists, neuropsychologists, and psychomotor therapists involved in the rehabilitation of post-stroke patients.

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study.
  • Patients who do not wish to benefit from advanced rehabilitation technology.
  • Healthcare professionals with no experience using advanced rehabilitation technologies.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Post-stroke patients

    This group includes patients with a confirmed diagnosis of stroke, hospitalized or followed at HCL - Renée Sabran Hospital (Kermes 2 department), regardless of whether they have previously used advanced rehabilitation technologies.

    Other: completion of a structured questionnaire

  • Physicians in Physical and Rehabilitation Medicine

    This group consists of physicians specialized in Physical and Rehabilitation Medicine, actively involved in the treatment and rehabilitation of post-stroke patients. Recruited from HCL - Renée Sabran Hospital and affiliated professional networks

    Other: completion of a structured questionnaire

  • Allied health professionals

    This group includes allied health professionals involved in stroke rehabilitation, such as physiotherapists, occupational therapists, psychologists, speech therapists, neuropsychologists, and psychomotor therapists. All participants are affiliated with the HCL - Renée Sabran Hospital or collaborating institutions

    Other: completion of a structured questionnaire

Interventions

  • Othercompletion of a structured questionnaire

    completion of a structured questionnaire

06

What researchers measure

Primary outcomes

  1. Perceptions of post-stroke patients, physical medicine and rehabilitation physicians and auxiliary medical staff on Advanced Rehabilitation Technologies.

    The primary outcome measure evaluates the perception of advanced rehabilitation technologies among key stakeholders involved in post-stroke recovery. This perception is assessed using a structured questionnaire specifically developed by the authors, designed to capture attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The instrument is applied to three target groups: post-stroke patients, physicians specializing in physical and rehabilitation medicine, and allied health professionals. This measure provides critical insights into the acceptability and potential integration of advanced technologies in neurorehabilitation practice.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • HCL - Renée Sabran Hospital
    Hyères, France
    Recruiting
    • Victor Andrei Stan, Dr · Contactvictor-andrei.stan@drd.umfcd.ro · +33772151051
    • victor-andrei STAN, Dr · Sub investigator
    • David PLANTIER, Dr · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jul 2026, 12 months after the start.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 12 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2025
First posted
May 23, 2025
StartActual
Jul 8, 2025
Primary completionEst.
Jul 8, 2026
CompletionEst.
Jul 8, 2026
Last update
Jul 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06986421
Responsible party
Sponsor
First posted
May 23, 2025
Start date
Jul 8, 2025
Primary completion
Jul 8, 2026 (estimated)
Completion
Jul 8, 2026 (estimated)
Last update
Jul 16, 2025

Study contacts

David PLANTIER, Dr
Contact
david.plantier@chu-lyon.fr
+33494381720
Victor-Andrei Stan, Dr
Contact
victor-andrei.stan@drd.umfcd.ro
+33772151051
David PLANTIER, DR
principal investigator · HCL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion